BSE NSE
Your Result on : Scheme Profile
Fund Family
Category
Scheme
Nippon India Pharma Fund - Direct (Bonus)
Summary Info
Fund Name : Nippon India Mutual Fund
Scheme Name : Nippon India Pharma Fund - Direct (Bonus)
AMC : Nippon India Mutual Fund
Type : Open
Category : Equity - Pharma
Launch Date : 01-Jan-13
Fund Manager : Sailesh Raj Bhan
Net Assets:(Rs in cr) 8080.97
NAV Graph
NAV Details
NAV Date : 02-May-25
NAV [Rs] : 548.79
Buy/Repurchase Price [Rs] : 0.00
Sell/Resale Price [Rs] : 0.00
Entry Load % : NIL
Exit Load % : 1% if redeemed or switchd out on or before completion of 1 Months from the date of allotment of units. NIl if redeemed or switched out after the completion of 1 Months from the date of allotment of units.
Latest Payouts
  Dividends Bonus
Ratio NA NA
Record Date NA NA
Investment Details
Tax Benefits : Section NA
Min. Investment (Rs) : 5000
Increm.Investment (Rs) : 1000
Performance(%)
  1 Week 1 Month 3 Month 6 Month 1 Year 3 Year 5 Year Since INC
Scheme Return 0.10 3.56 3.00 -3.66 15.88 21.09 23.48 18.13
Category Avg -0.05 2.01 -0.39 -5.07 17.37 20.77 22.84 17.17
Category Best 0.75 3.56 3.00 -0.74 28.94 25.44 26.30 36.21
Category Worst -2.32 -0.74 -4.75 -11.31 4.96 15.92 17.19 -8.37
Statistical Ratios
What is Beta ?
Beta is a measure of the volatility of the portfolio to that of the index. In simple words it shows the movement of the portfolio in comparison. The Higher the Beta, higher the volatility of the scheme to the index. If its greater than1 , then the portfolio is highly volatile to the movemnts in the index. If the beta is lesser than 1 , then scheme is less volatile to the index and beta which is close to 1 implies that the scheme is closely following the index.
  Beta [%] SD [%] Sharpe Ratio [%] Jensons Alpha [%] ER [%]
  0.7741 4.5758 0.8193 9.8741 0.0683
* Move mouse over the headings to view the definitions.
Asset Allocation
Holdings 31-Mar-25
Company Name % Hold
Sun Pharma.Inds. 13.43
Divi's Lab. 9.28
Lupin 7.27
Cipla 5.71
Apollo Hospitals 5.31
Dr Reddy's Labs 5.19
Glaxosmi. Pharma 3.61
Vijaya Diagnost. 3.53
Abbott India 3.46
Medplus Health 3.41
Ajanta Pharma 3.11
Gland Pharma 3.01
Narayana Hrudaya 2.99
Aurobindo Pharma 2.45
Zydus Lifesci. 2.19
Dr Lal Pathlabs 2.18
Torrent Pharma. 2.01
J B Chemicals & 2.01
Alkem Lab 1.96
Mankind Pharma 1.95
Sanofi India 1.63
Pfizer 1.58
Thyrocare Tech. 1.49
Ipca Labs. 1.46
Sai Life 1.35
Sanofi Consumer 1.28
Suraksha Diagno. 1.02
Syngene Intl. 1.01
Biocon 0.97
Fortis Health. 0.95
Astrazeneca Phar 0.68
Indoco Remedies 0.53
Orchid Pharma 0.47
Emcure Pharma 0.40
Krishna Institu. 0.37
Concord Biotech 0.23
TREPS 0.70
Net CA & Others -0.18
C C I 0.00
Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)